Misonix Announces New Distribution Agreement for Baltic Countries

FARMINGDALE, N.Y., May 22, 2012 /PRNewswire via COMTEX/ — Misonix, Inc. (nasdaqgm:MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications has entered into a new, three year, exclusive distribution agreement with Apex Medicus, based in Vilnius, Lithuania, for the distribution of the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter. The agreement provides Apex Medicus with the right to sell throughout Estonia, Latvia and Lithuania. Included in the agreement are annual minimum purchase requirements. Product training is complete and open market sales have begun.
Apex Medicus is well established in neurosurgery and skull-based surgery and has earned a reputation for successfully introducing high tech products to the Baltic countries. Their commitment to product support and education is consistent with the Company’s core values.
The SonaStar is used by neurosurgeons and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. OsteoSculpt(TM) bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.
“We are very pleased to add Apex Medicus to our distribution organization in Europe; their presence fills one of our remaining coverage gaps. We now have a well-rounded distribution operation throughout the Continent with highly regarded partners in their respective markets. We are now well positioned to effectively penetrate these markets and establish Misonix as a leading surgical instruments provider,” said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. “We look forward to the opportunities ahead with great anticipation.”